₹2,072.00 7.00 (0.34%)
04:01 PM, 14-May-2025₹2,071.40 7.00 (0.34%)
03:54 PM, 14-May-2025BSE : 500257
NSE : LUPIN
Sector : Health care
ISIN Code : INE326A01037
Last Updated: 14-May-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 94,608 |
Traded Value (₹ Cr) | 4.36 |
Volume (Shares) | 21,048 |
Face Value (₹) | 2 |
52-Week High (₹) | 2,403.45 |
52-Week High Date | 02-Jan-2025 |
52-Week Low (₹) | 1,493.75 |
52-Week Low Date | 04-Jun-2024 |
All Time High (₹) | 2,403.45 |
All Time High Date | 02-Jan-2025 |
All Time Low (₹) | 0.80 |
All Time Low Date | 12-Apr-2001 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 94,580 |
EPS - TTM (₹) [C] | 62.82 |
P/E Ratio (X) [C] | 32.97 |
Face Value (₹) | 2 |
Latest Dividend (%) | 400.00 |
Latest Dividend Date | 16-Jul-2024 |
Dividend Yield (%) | 0.39 |
Book Value Share (₹) [C] | 342.56 |
P/B Ratio (₹) [C] | 6.05 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HDFC Balanced Advantage Fund (G) | 1179.94 | 56,30,582 | 1.21 |
HDFC Balanced Advantage Fund (IDCW) | 1179.94 | 56,30,582 | 1.21 |
HDFC Balanced Advantage Fund - Direct (IDCW) | 1179.94 | 56,30,582 | 1.21 |
HDFC Balanced Advantage Fund - Direct (G) | 1179.94 | 56,30,582 | 1.21 |
HDFC Large Cap Fund - Regular (IDCW) | 706.01 | 33,69,013 | 1.89 |
HDFC Large Cap Fund - Regular (G) | 706.01 | 33,69,013 | 1.89 |
HDFC Large Cap Fund - Direct (IDCW) | 706.01 | 33,69,013 | 1.89 |
HDFC Large Cap Fund - Direct (G) | 706.01 | 33,69,013 | 1.89 |
Mirae Asset Large & Midcap Fund - Regular (G) | 641.11 | 30,59,328 | 1.70 |
Mirae Asset Large & Midcap Fund - Regular (IDCW) | 641.11 | 30,59,328 | 1.70 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
11-Nov-2024 | Elara Capital | Accumulate | 2,392 | |
11-Jul-2024 | ICICI Securities | Reduce | 1,615 | |
08-May-2024 | Elara Capital | Accumulate | 1,820 | |
26-Jun-2023 | ICICI Securities | Sell | 740 |
Today's Low/High (₹) | 2,035.80 2,086.00 |
Week Low/High (₹) | 1,974.00 2,114.00 |
Month Low/High (₹) | 1,921.00 2,150.00 |
Year Low/High (₹) | 1,493.30 2,403.00 |
All time Low/High (₹) | 0.80 2,403.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 0.02% | 0.00% | 0.72% | 1.03% |
1 Month | 5.20% | 5.19% | 8.21% | 8.05% |
3 Month | 5.22% | 5.15% | 7.10% | 7.58% |
6 Month | 2.88% | 2.76% | 4.83% | 4.82% |
1 Year | 26.59% | 26.52% | 11.25% | 11.02% |
3 Year | 197.49% | 197.47% | 54.05% | 56.30% |
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Off : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Executive Director & CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Punita Kumar Sinha
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Registered Office: Kalpataru Inspire 3rd Floor, Off Western Exp HW Santacruz-E,Mumbai,Maharashtra-400055 Ph: 91-22-6640 2323
1. What's the Lupin Ltd share price today?
Lupin Ltd share price was Rs 2,072.00 at 04:01 PM IST on 14th May 2025. Lupin Ltd share price was up by 0.34% over the previous closing price of Rs 2,065.00. Lupin Ltd share price trend:
2. How can I quickly analyse the performance of the Lupin Ltd stock?
The performance of the Lupin Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Lupin Ltd?
Lupin Ltd has a market capitalisation of Rs 94,608 crore.
4. What is Lupin Ltd's 52-week high/low share price?
The Lupin Ltd’s 52-week high share price is Rs 2,403.45 and 52-week low share price is Rs 1,493.75.
5. Is the Lupin Ltd profitable?
On a consolidated basis, Lupin Ltd reported a profit of Rs 858.86 crore on a total income of Rs 5,821.42 crore for the quarter ended 2024. For the year ended 2024, Lupin Ltd had posted a profit of Rs 1,935.57 crore on a total income of Rs 20,010.82 crore.
6. Which are Lupin Ltd’s peers in the Health care sector?
Lupin Ltd’s top 5 peers in the Health care sector are Torrent Pharma., Mankind Pharma, Dr Reddy's Labs, Lupin, Zydus Lifesci., Aurobindo Pharma, Abbott India.
7. Who owns how much in Lupin Ltd?
Key changes to the Lupin Ltd shareholding are as follows: